• Featured Product
  • KD/KO Validated

Cathepsin L Monoclonal antibody, PBS Only

Cathepsin L Monoclonal Antibody for WB, IHC, IF/ICC, Indirect ELISA

Host / Isotype

Mouse / IgG2b

Reactivity

human, mouse, rat

Applications

WB, IHC, IF/ICC, Indirect ELISA

Conjugate

Unconjugated

CloneNo.

1A12G8

Cat no : 66914-1-PBS

Print datasheet

Synonyms

CTSL1, CATL, cathepsinL1, cathepsin L1, Cathepsin L light chain



Planning an IHC experiment? We recommend our IHCeasy CTSL1 Ready-To-Use IHC Kit. CTSL1 primary antibody included.

产品信息

66914-1-PBS targets Cathepsin L in WB, IHC, IF/ICC, Indirect ELISA applications and shows reactivity with human, mouse, rat samples.

Tested Applications WB, IHC, IF/ICC, Indirect ELISA Application Description
Tested Reactivity human, mouse, rat
Immunogen Cathepsin L fusion protein Ag27951 种属同源性预测
Host / Isotype Mouse / IgG2b
Class Monoclonal
Type Antibody
Full Name cathepsin L1
Synonyms CTSL1, CATL, cathepsinL1, cathepsin L1, Cathepsin L light chain
Calculated Molecular Weight 38 kDa
Observed Molecular Weight43 kDa
GenBank Accession NumberBC012612
Gene Symbol Cathepsin L
Gene ID (NCBI) 1514
Conjugate Unconjugated
Form Liquid
Purification MethodProtein A purification
UNIPROT IDP07711
Storage Buffer PBS Only
Storage ConditionsStore at -80°C.
The product is shipped with ice packs. Upon receipt, store it immediately at -80°C

背景介绍

CTSL1(Cathepsin L1) is also named as CTSL and MEP, belongs to the peptidase C1 family. It is a lysosomal proteinase whose expression is also up-regulated in the skeletal muscle during starvation(PMID:20088826). It plays an intracellular role in normal intestinal epithelial polarization and initiation of neoplasia(PMID:17622569). CTSL1 also improves cardiac function and inhibits cardiac hypertrophy, inflammation, and fibrosis through blocking AKT/GSK3B signaling(PMID:19096818). The full length protein is 38 kDa with a signal peptide, two propeptide and a glycosylation site. It has been detected the 36 kDa, 39 kDa, 29 kDa and 21 kDa in rat gastrocnemius muscle. These forms of cathepsin L could either be attributed to differences in glycosylation or to partial processing of the proenzyme. (PMID:11696001)